Financials & Filings Show all 2022 Q4 Harvard Bioscience Announces Fourth Quarter 2022 Financial Results Q4 2022 Harvard Bioscience, Inc. Earnings Conference Call Earnings Presentation 887.9 KB Form 10-K Proxy Statements Filing date View Apr 30, 2001 0000912057-01-511426.pdf 0000912057-01-511426.rtf View HTML Apr 17, 2002 0000912057-02-015510.pdf 0000912057-02-015510.rtf 0000912057-02-015510.xls View HTML Form 10-K Filing date View Apr 1, 2002 View HTML 0001104659-02-001297.pdf 0001104659-02-001297.rtf 0001104659-02-001297.xls Mar 31, 2003 View HTML 0001104659-03-005531.pdf 0001104659-03-005531.rtf 0001104659-03-005531.xls Form 10-Q Filing date View May 15, 2001 0001104659-01-500684.pdf 0001104659-01-500684.rtf 0001104659-01-500684.xls View HTML Aug 14, 2001 0001104659-01-501760.pdf 0001104659-01-501760.rtf 0001104659-01-501760.xls View HTML Shareholder Tools Printed Materials Email Alerts RSS Print Share Facebook LinkedIn Twitter RSS
Financials & Filings Show all 2022 Q4 Harvard Bioscience Announces Fourth Quarter 2022 Financial Results Q4 2022 Harvard Bioscience, Inc. Earnings Conference Call Earnings Presentation 887.9 KB Form 10-K Proxy Statements Filing date View Apr 30, 2001 0000912057-01-511426.pdf 0000912057-01-511426.rtf View HTML Apr 17, 2002 0000912057-02-015510.pdf 0000912057-02-015510.rtf 0000912057-02-015510.xls View HTML Form 10-K Filing date View Apr 1, 2002 View HTML 0001104659-02-001297.pdf 0001104659-02-001297.rtf 0001104659-02-001297.xls Mar 31, 2003 View HTML 0001104659-03-005531.pdf 0001104659-03-005531.rtf 0001104659-03-005531.xls Form 10-Q Filing date View May 15, 2001 0001104659-01-500684.pdf 0001104659-01-500684.rtf 0001104659-01-500684.xls View HTML Aug 14, 2001 0001104659-01-501760.pdf 0001104659-01-501760.rtf 0001104659-01-501760.xls View HTML
